Clauser Noah 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Sep 21, 2020
Insider Transaction Report
Form 4
Clauser Noah
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2020-09-17+35,000→ 35,000 totalExercise: $6.94Exp: 2030-09-16→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option was granted on September 17, 2020 and is subject to vesting over a four year period with 25% of the shares vesting on the first anniversary of September 17, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.